[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2160796T3 - Moleculas quimericas ribozima-arnsn que tienen actividad catalitica para arns nucleares. - Google Patents

Moleculas quimericas ribozima-arnsn que tienen actividad catalitica para arns nucleares.

Info

Publication number
ES2160796T3
ES2160796T3 ES96830641T ES96830641T ES2160796T3 ES 2160796 T3 ES2160796 T3 ES 2160796T3 ES 96830641 T ES96830641 T ES 96830641T ES 96830641 T ES96830641 T ES 96830641T ES 2160796 T3 ES2160796 T3 ES 2160796T3
Authority
ES
Spain
Prior art keywords
ribozima
catalytic activity
arnsn
arns
nuclear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96830641T
Other languages
English (en)
Inventor
I Bozzoni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universita degli Studi di Roma La Sapienza
Original Assignee
Universita degli Studi di Roma La Sapienza
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universita degli Studi di Roma La Sapienza filed Critical Universita degli Studi di Roma La Sapienza
Application granted granted Critical
Publication of ES2160796T3 publication Critical patent/ES2160796T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121—Hammerhead

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE DESCRIBEN MOLECULAS QUIMERICAS DE SNARN-RIBOZIMA, UTILIZADAS EN TERAPIA, PARA TRANSPORTAR EFICIENTEMENTE IN VIVO, MOLECULAS CON ACTIVIDAD CATALITICA SOBRE UN SUSTRATO DE ARN. DICHAS MOLECULAS SON UTILIZADAS PREFERIBLEMENTE EN TERAPIA ANTIVIRAL, PREFERIBLEMENTE ANTI VIH.
ES96830641T 1996-01-12 1996-12-20 Moleculas quimericas ribozima-arnsn que tienen actividad catalitica para arns nucleares. Expired - Lifetime ES2160796T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000017A IT1283876B1 (it) 1996-01-12 1996-01-12 Molecole chimeriche ribozima-snrna ad attivita' catalitica per rna a localizzazione nucleare

Publications (1)

Publication Number Publication Date
ES2160796T3 true ES2160796T3 (es) 2001-11-16

Family

ID=11403768

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96830641T Expired - Lifetime ES2160796T3 (es) 1996-01-12 1996-12-20 Moleculas quimericas ribozima-arnsn que tienen actividad catalitica para arns nucleares.

Country Status (6)

Country Link
US (1) US5994124A (es)
EP (1) EP0784094B1 (es)
AT (1) ATE202143T1 (es)
DE (1) DE69613336T2 (es)
ES (1) ES2160796T3 (es)
IT (1) IT1283876B1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274369B1 (en) * 1996-02-02 2001-08-14 Invitrogen Corporation Method capable of increasing competency of bacterial cell transformation
US6692910B2 (en) * 1997-07-28 2004-02-17 The University Of Connecticut Inhibition of a target messenger RNA with a modified U1 small nuclear RNA
CN1294631A (zh) 1998-03-20 2001-05-09 贝尼泰克澳大利亚有限公司 控制基因表达
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
US20030036519A1 (en) * 1998-04-21 2003-02-20 Ryszard Kole Stable alteration of pre-mrna splicing patterns by modified rnas
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
AUPR621501A0 (en) 2001-07-06 2001-08-02 Commonwealth Scientific And Industrial Research Organisation Delivery of ds rna
EP1578767A4 (en) * 2002-12-04 2008-01-09 Algos Therapeutics Inc METHOD AND MATERIALS FOR MODULATING TRPM2
CA2520664A1 (en) * 2003-03-27 2004-10-14 Ptc Therapeutics, Inc. Targeting enzymes of the trna splicing pathway for identification of anti-fungal and/or anti-proliferative molecules
WO2004087070A2 (en) * 2003-03-27 2004-10-14 Ptc Therapeutics, Inc. METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-FUNGAL AGENTS
JP4634371B2 (ja) * 2003-03-27 2011-02-16 ピーティーシー セラピューティクス，インコーポレーテッド ｔＲＮＡスプライシングエンドヌクレアーゼに標的化する化合物の同定方法、および該化合物の抗増殖剤としての使用
US20050053985A1 (en) * 2003-07-02 2005-03-10 Ptc Therapeutics, Inc. RNA processing protein complexes and uses thereof
CA2568603A1 (en) * 2003-09-12 2005-03-24 Commonwealth Scientific And Industrial Research Organisation Modified gene-silencing nucleic acid molecules and uses thereof
US9040491B2 (en) * 2006-08-30 2015-05-26 The Trustees Of The University Of Pennsylvania Compositions, methods and kits based on small nuclear RNAs
EP2152873A2 (en) * 2007-03-16 2010-02-17 Biorigen S.r.l Gene expression regulation technology and noncoding rnas for diagnosis and therapy
US9470350B2 (en) 2013-07-23 2016-10-18 Spencer Composites Corporation Metal-to-composite interfaces
IL311101A (en) * 2021-09-03 2024-04-01 Tacit Therapeutics Inc RNA editing through recruitment of SPLICEOSOME components
WO2023168458A1 (en) 2022-03-04 2023-09-07 Locanabio, Inc. Compositions and methods comprising engineered small nuclear rna (snrna)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2114312A1 (en) * 1992-05-27 1993-12-09 John J. Rossi Chimeric trnalys-ribozyme molecules
EP0703987A1 (en) * 1993-06-18 1996-04-03 Novartis AG Chimeric plant genes possessing independent regulatory sequences
US5695938A (en) * 1994-12-09 1997-12-09 City Of Hope Anti-HIV ribozymes

Also Published As

Publication number Publication date
ATE202143T1 (de) 2001-06-15
ITRM960017A0 (it) 1996-01-12
ITRM960017A1 (it) 1997-07-12
EP0784094B1 (en) 2001-06-13
IT1283876B1 (it) 1998-05-07
US5994124A (en) 1999-11-30
DE69613336D1 (de) 2001-07-19
DE69613336T2 (de) 2002-04-18
EP0784094A1 (en) 1997-07-16

Similar Documents

Publication Publication Date Title
ES2160796T3 (es) Moleculas quimericas ribozima-arnsn que tienen actividad catalitica para arns nucleares.
DE3877039D1 (de) Stabiles, wasserstoffperoxid enthaltendes zahngel.
BR9816155B1 (pt) imidazotriazinonas 2-fenil-substituìdas como inibidores de fosfodiesterase, bem como medicamento e uso farmacêutico compreendendo as mesmas.
ES2105698T3 (es) Oligonucleotidos modificados con 7-deazapurina.
ES2138271T3 (es) Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico.
HN1996000017A (es) Isotiazolonas
BR9507852A (pt) Processo para hidrocianação e composição de catalisador
MX9203504A (es) Complejo agente: lipido activo de alta proporcion.
ES2183978T3 (es) Complejos metalicos que contienen indenilo sustituido y procedimiento de polimerizacion de olefinas.
ES2080721T3 (es) Agentes tensoactivos de silicona.
NO871382L (no) Fargeloese ketiminer, fremstilling av dem og anvendelse derav som kryssbindingsmiddel.
TR200201071T2 (tr) Rar selektif retinoid antagonistleri kullanılarak anfizem tedavisi
NO915083D0 (no) Hydrogenbehandlingskatalysator
ES2176216T3 (es) Particulas de ceramica y su preparacion.
TR200001486T2 (tr) Hiperkeratozlu deri hastalıklarının tedavisi için diol ve alfa-hidroksi asitten oluşan bir karışımın kullanılması
ES2153814T3 (es) Analogos de cc-1065 que tienen dos subunidades cpi.
FI905005A0 (fi) Triglycerider innehaollande maettade c20-24-fettsyror, anvaendbara till att saenka kolesterolhalten i blodet.
DE69229059D1 (de) Wasserstoffbehandlungskatalysator
ES2133634T3 (es) Sistemas catalizadores metalocenicos portados.
FI872943A (fi) Reaktor avsedd foer att alstra biogas.
BR9801143A (pt) Copolìmeros de bloco de siloxano inovativos com espaçamento rìgidos e uso dos mesmos.
ATE206864T1 (de) Zinkenblatt, insbesondere für zinkenträger
MX219608B (es) Hidrogenacion de un compuesto antraquinoa en presencia de un catalizador que consiste en, como metal activo, cuando menos un metal del grupo de transicion vIII de la tabla periodica de los elementos
DE69807200D1 (de) Inklusionskomplexe in waessriger loesung
BR9801379A (pt) Processo de preparação de dinitroanilinas dissubstituidas em 3,4

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 784094

Country of ref document: ES